Please login to the form below

Not currently logged in
Email:
Password:

Teva Generics Europe appoints president and CEO

Promotes former UK general manager Richard Daniell

Teva Richard DaniellTeva has appointed Richard Daniell as president and chief executive officer of Teva Generics Europe, following Dipankar Bhattacharjee's promotion to a global role.

Daniell has over 25 years of experience working at Teva and served as the company's chief integration officer, leading the integration programme to bring Actavis and Teva together.

Prior to this, he was chief operating officer, growth markets region and served as general manager of Teva UK from 2011 to 2015.

Bhattacharjee, president and chief executive of global generic medicines said: “Richard has shown visionary leadership, has built high-performing teams across the company and has an impressive record in driving commercial success.”

21st December 2016

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...
Employee engagement
Route 66: can remote working put two-thirds of us back on the road to engaged employment?
Pre-pandemic, 66% of the world’s workforce weren’t engaged in their jobs – Chris Ross examines how the rush to remote working has impacted employee engagement...
Demonstrating the value of HCP self-serve portals
Develop the art of setting KPIs and metrics aligned to your specific objectives, target personas, key educational messages, content, website features and journeys....

Infographics